| Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway A Augello, R Tasso, SM Negrini, A Amateis, F Indiveri, R Cancedda, ... European journal of immunology 35 (5), 1482-1490, 2005 | 967 | 2005 |
| Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen‐induced arthritis A Augello, R Tasso, SM Negrini, R Cancedda, G Pennesi Arthritis & Rheumatism 56 (4), 1175-1186, 2007 | 779 | 2007 |
| Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization C Lo Sicco, D Reverberi, C Balbi, V Ulivi, E Principi, L Pascucci, ... Stem cells translational medicine 6 (3), 1018-1028, 2017 | 479 | 2017 |
| The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and … F Tortelli, R Tasso, F Loiacono, R Cancedda Biomaterials 31 (2), 242-249, 2010 | 171 | 2010 |
| Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds R Tasso, A Augello, M Carida’, F Postiglione, MG Tibiletti, B Bernasconi, ... Carcinogenesis 30 (1), 150-157, 2009 | 144 | 2009 |
| Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis R Tasso, C Ilengo, R Quarto, R Cancedda, RR Caspi, G Pennesi Investigative ophthalmology & visual science 53 (2), 786-793, 2012 | 128 | 2012 |
| Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS) S Tavella, A Ruggiu, A Giuliani, F Brun, B Canciani, A Manescu, ... PLoS one 7 (3), e33179, 2012 | 113 | 2012 |
| The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model R Tasso, F Fais, D Reverberi, F Tortelli, R Cancedda Biomaterials 31 (8), 2121-2129, 2010 | 111 | 2010 |
| Extracellular vesicles as biomarkers and therapeutic tools: from pre-clinical to clinical applications MC Ciferri, R Quarto, R Tasso Biology 10 (5), 359, 2021 | 106 | 2021 |
| Mesenchymal stem cell paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a … V Ulivi, R Tasso, R Cancedda, F Descalzi Stem cells and development 23 (16), 1858-1869, 2014 | 101 | 2014 |
| Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic R Tasso, A Augello, S Boccardo, S Salvi, M Carida, F Postiglione, F Fais, ... Tissue Engineering Part A 15 (8), 2203-2212, 2009 | 99 | 2009 |
| Extracellular vesicles as natural, safe and efficient drug delivery systems F Villa, R Quarto, R Tasso Pharmaceutics 11 (11), 557, 2019 | 96 | 2019 |
| The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model R Tasso, M Gaetani, E Molino, A Cattaneo, M Monticone, A Bachi, ... Biomaterials 33 (7), 2086-2096, 2012 | 96 | 2012 |
| An Alu‐like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells M Castelnuovo, S Massone, R Tasso, G Fiorino, M Gatti, M Robello, ... The FASEB Journal 24 (10), 4033-4046, 2010 | 88 | 2010 |
| The regenerative role of the fetal and adult stem cell secretome S Bollini, C Gentili, R Tasso, R Cancedda Journal of clinical medicine 2 (4), 302-327, 2013 | 87 | 2013 |
| Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells S Vella, M Conti, R Tasso, R Cancedda, A Pagano International journal of cancer 130 (7), 1484-1493, 2012 | 87 | 2012 |
| In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche R Tasso, V Ulivi, D Reverberi, C Lo Sicco, F Descalzi, R Cancedda Stem cells and development 22 (24), 3178-3191, 2013 | 71 | 2013 |
| Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and … C Gorgun, D Ceresa, R Lesage, F Villa, D Reverberi, C Balbi, ... Biomaterials 269, 120633, 2021 | 69 | 2021 |
| Delivery of cellular factors to regulate bone healing A Haumer, PE Bourgine, P Occhetta, G Born, R Tasso, I Martin Advanced drug delivery reviews 129, 285-294, 2018 | 58 | 2018 |
| When stem cells meet immunoregulation R Tasso, G Pennesi International Immunopharmacology 9 (5), 596-598, 2009 | 49 | 2009 |
